Health

An FDA advisory committee recently voted 11-5 in favor of the efficacy of arimoclomol, an investigative treatment for Niemann-Pick disease type C. However, despite the majority vote, some committee members still expressed concerns about the treatment. If the FDA ultimately approves arimoclomol, it would be the first indicated treatment for this ultra-rare and fatal neurovisceral
0 Comments
The FDA recently granted accelerated approval to afamitresgene autoleucel (afami-cel, Tecelra) for the treatment of advanced synovial sarcoma, marking a significant milestone in cancer therapy. This engineered cell therapy represents a new option for patients with unresectable or metastatic disease who have previously undergone chemotherapy. Synovial sarcoma is a rare soft-tissue cancer that predominantly affects
0 Comments
The recently released proposed Medicare fee schedule for physicians and other healthcare professionals in 2025 has sparked concerns within the healthcare community. One of the primary issues highlighted in the proposal is the significant decrease in the Medicare “conversion factor” (CF), which is used to determine payment rates for services and procedures. This decrease means
0 Comments
North Carolina Governor Roy Cooper’s administration recently received approval from the Centers for Medicare & Medicaid Services (CMS) for a groundbreaking proposal aimed at providing financial incentives to hospitals in the state. The goal of this initiative is to help hospitals eliminate patients’ medical debt and implement policies that deter future liabilities. Under this new
0 Comments
The excitement surrounding MDMA-assisted therapy for PTSD in veterans reached new heights when VA Under-Secretary for Health Shereef Elnahal, MD, expressed the agency’s readiness to roll out this treatment option. However, this optimism was short-lived as FDA advisers later voted against the drug due to concerns about flawed data, questionable research conduct, and potential safety
0 Comments
A recent study challenged some commonly held beliefs about how the H5N1 bird flu behaves in cattle. While it was previously thought that the virus usually caused only mild illness and that asymptomatic animals did not spread the disease, new findings have shed light on a different reality. The study, conducted by Kiril Dimitrov, DVM,
0 Comments